The protective effect of Hif3a RNA interference and HIF-prolyl hydroxylase inhibition on cardiomyocytes under...

Area of Science:

• Cardiology
• Molecular Biology
• Cellular Physiology

Background:

• Anoxia-reoxygenation (A/R) injury is a significant cause of cardiomyocyte damage.
• Hypoxia-inducible factor (HIF) signaling plays a crucial role in cellular adaptation to low oxygen conditions.

Purpose of the Study:

• To investigate the molecular mechanisms of HIF signaling pathway activation in protecting cardiomyocytes against A/R injury.
• To evaluate the effects of HIF3A silencing and HIF-prolyl hydroxylase inhibition on cardiomyocyte viability and function during A/R.

Main Methods:

• Primary culture of rat neonatal cardiomyocytes.
• Pretreatment with anti-Hif3A/Hif-3α siRNA or a HIF-prolyl hydroxylase inhibitor.
• Induction of A/R injury model.
• Assessment of cell viability, mitochondrial membrane potential (Δψ_m), and mRNA expression of HIF1-target genes.

Main Results:

• Both HIF3A silencing and HIF-prolyl hydroxylase inhibition significantly increased cardiomyocyte viability during A/R.
• These interventions reduced the loss of mitochondrial membrane potential (Δψ_m).
• Upregulation of HIF1-target genes, including Epo, Igf1, Slc2a1/Glut-1, Slc2a4/Glut-4, Epor, Tert, and Pdk1, was observed.

Conclusions:

• HIF3A RNA interference and HIF-prolyl hydroxylase inhibition confer protection to cardiomyocytes against A/R injury.
• The protective effects are mediated through the HIF signaling pathway.
• These findings highlight potential therapeutic strategies for ischemic heart disease.